BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36613208)

  • 1. Comparisons of Effectiveness in Differentiating Benign from Malignant Ovarian Masses between Conventional and Modified Risk of Malignancy Index (RMI).
    Tantipalakorn C; Tinnangwattana D; Lerthiranwong T; Luewan S; Tongsong T
    Int J Environ Res Public Health; 2023 Jan; 20(1):. PubMed ID: 36613208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses.
    Auekitrungrueng R; Tinnangwattana D; Tantipalakorn C; Charoenratana C; Lerthiranwong T; Wanapirak C; Tongsong T
    Int J Gynaecol Obstet; 2019 Sep; 146(3):364-369. PubMed ID: 31206642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of a risk of malignancy index in clinical approaches to adnexal masses.
    Simsek HS; Tokmak A; Ozgu E; Doganay M; Danisman N; Erkaya S; Gungor T
    Asian Pac J Cancer Prev; 2014; 15(18):7793-7. PubMed ID: 25292065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the predictive performance of risk of malignancy indexes 1-4, HE4 and risk of malignancy algorithm in the triage of adnexal masses.
    Hada A; Han LP; Chen Y; Hu QH; Yuan Y; Liu L
    J Ovarian Res; 2020 Apr; 13(1):46. PubMed ID: 32334618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the risk malignancy index diagnostic value in patients with adnexal masses.
    Terzić M; Dotlić J; Ladjević IL; Atanacković J; Ladjević N
    Vojnosanit Pregl; 2011 Jul; 68(7):589-93. PubMed ID: 21899180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accuracy of risk malignancy index in prediction of malignancy in women with adnexal mass in Basrah, Iraq.
    Al-Asadi JN; Al-Maliki SK; Al-Dahhhan F; Al-Naama L; Suood F
    Niger J Clin Pract; 2018 Oct; 21(10):1254-1259. PubMed ID: 30297555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of malignancy index for adnexal masses.
    Akdeniz N; Kuyumcuoğlu U; Kale A; Erdemoğlu M; Caca F
    Eur J Gynaecol Oncol; 2009; 30(2):178-80. PubMed ID: 19480249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?
    Yavuzcan A; Caglar M; Ozgu E; Ustun Y; Dilbaz S; Ozdemir I; Yildiz E; Gungor T; Kumru S
    Asian Pac J Cancer Prev; 2013; 14(9):5455-9. PubMed ID: 24175841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.
    Van Gorp T; Veldman J; Van Calster B; Cadron I; Leunen K; Amant F; Timmerman D; Vergote I
    Eur J Cancer; 2012 Jul; 48(11):1649-56. PubMed ID: 22226481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of malignancy index in discrimination of adnexal masses.
    Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
    Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ultrasound score, CA125, menopausal status, and risk of malignancy index in differentiating between benign and borderline or malignant ovarian tumors.
    Leelahakorn S; Tangjitgamol S; Manusirivithaya S; Thongsuksai P; Jaroenchainon P; Jivangkul C
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S22-30. PubMed ID: 17718292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
    Dora SK; Dandapat AB; Pande B; Hota JP
    J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of risk of malignancy indices in evaluating ovarian masses in a Southeast Asian population.
    Ong C; Biswas A; Choolani M; Low JJ
    Singapore Med J; 2013 Mar; 54(3):136-9. PubMed ID: 23546025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the risk of malignancy in adnexal masses: validation of O-RADS and comparison with ADNEX model, SA, and RMI.
    Wang R; Yang Z
    Ginekol Pol; 2023; 94(10):799-806. PubMed ID: 36929789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of malignancy index in the evaluation of patients with adnexal masses.
    Clarke SE; Grimshaw R; Rittenberg P; Kieser K; Bentley J
    J Obstet Gynaecol Can; 2009 May; 31(5):440-5. PubMed ID: 19604425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonographic discrimination between benign and malignant adnexal masses in premenopause.
    Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E
    Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of malignancy index (RMI) in women with adnexal masses in Wales.
    Abdulrahman GO; McKnight L; Lutchman Singh K
    Taiwan J Obstet Gynecol; 2014 Sep; 53(3):376-81. PubMed ID: 25286794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.